Cargando…

Irisin Serum Levels and Skeletal Muscle Assessment in a Cohort of Charcot-Marie-Tooth Patients

BACKGROUND: Charcot-Marie-Tooth (CMT) indicates a group of inherited polyneuropathies whose clinical phenotypes primarily include progressive distal weakness and muscle atrophy. Compelling evidence showed that the exercise-mimetic myokine irisin protects against muscle wasting in an autocrine manner...

Descripción completa

Detalles Bibliográficos
Autores principales:	Colaianni, Graziana, Oranger, Angela, Dicarlo, Manuela, Lovero, Roberto, Storlino, Giuseppina, Pignataro, Patrizia, Fontana, Antonietta, Di Serio, Francesca, Ingravallo, Angelica, Caputo, Giuseppe, Di Leo, Alfredo, Barone, Michele, Grano, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134857/ https://www.ncbi.nlm.nih.gov/pubmed/35634506 http://dx.doi.org/10.3389/fendo.2022.886243

Ejemplares similares

Antidepressant Effect of Intermittent Long-Term Systemic Administration of Irisin in Mice
por: Pignataro, Patrizia, et al.
Publicado: (2022)

Time-dependent unloading effects on muscle and bone and involvement of FNDC5/irisin axis
por: Sanesi, Lorenzo, et al.
Publicado: (2023)

Irisin Protects against Loss of Trabecular Bone Mass and Strength in Adult Ovariectomized Mice by Stimulating Osteoblast Activity
por: Storlino, Giuseppina, et al.
Publicado: (2023)

Irisin and Secondary Osteoporosis in Humans
por: Zerlotin, Roberta, et al.
Publicado: (2022)

Once-Daily Subcutaneous Irisin Administration Mitigates Depression- and Anxiety-like Behavior in Young Mice
por: Pignataro, Patrizia, et al.
Publicado: (2023)

Short-Term Irisin Treatment Enhanced Neurotrophin Expression Differently in the Hippocampus and the Prefrontal Cortex of Young Mice
por: Dicarlo, Manuela, et al.
Publicado: (2023)

Irisin Modulates Inflammatory, Angiogenic, and Osteogenic Factors during Fracture Healing
por: Oranger, Angela, et al.
Publicado: (2023)

Irisin and Bone: From Preclinical Studies to the Evaluation of Its Circulating Levels in Different Populations of Human Subjects
por: Colaianni, Graziana, et al.
Publicado: (2019)

Irisin Enhances Osteoblast Differentiation In Vitro
por: Colaianni, Graziana, et al.
Publicado: (2014)

The Myokine Irisin Promotes Osteogenic Differentiation of Dental Bud-Derived MSCs
por: Posa, Francesca, et al.
Publicado: (2021)

Vitamin D Increases Irisin Serum Levels and the Expression of Its Precursor in Skeletal Muscle
por: Sanesi, Lorenzo, et al.
Publicado: (2023)

Diagnosis of Charcot-Marie-Tooth Disease
por: Banchs, Isabel, et al.
Publicado: (2009)

Charcot–Marie–Tooth disease and intracellular traffic
por: Bucci, Cecilia, et al.
Publicado: (2012)

Noncompaction Cardiomyopathy with Charcot-Marie-Tooth Disease
por: Eltawansy, Sherif Ali, et al.
Publicado: (2015)

Anejaculation in a patient with Charcot–Marie–Tooth
por: Cannarella, Rossella, et al.
Publicado: (2018)

Charcot-Marie-Tooth: From Molecules to Therapy
por: Morena, Jonathan, et al.
Publicado: (2019)

Audiological findings in the Charcot-Marie-Tooth Disease
por: Fukushima, Erika, et al.
Publicado: (2015)

Circulating Irisin Levels in Patients with Chronic Plaque Psoriasis
por: Ambrogio, Francesca, et al.
Publicado: (2022)

The Novel Role of PGC1α in Bone Metabolism
por: Buccoliero, Cinzia, et al.
Publicado: (2021)

Systemic Administration of Recombinant Irisin Accelerates Fracture Healing in Mice
por: Colucci, Silvia Concetta, et al.
Publicado: (2021)

Irisin Role in Chondrocyte 3D Culture Differentiation and Its Possible Applications
por: Posa, Francesca, et al.
Publicado: (2023)

Elevated Expression of ADAM10 in Skeletal Muscle of Patients with Idiopathic Inflammatory Myopathies Could Be Responsible for FNDC5/Irisin Unbalance
por: Zerlotin, Roberta, et al.
Publicado: (2023)

Charcot-Marie-Tooth Disease: Seventeen Causative Genes
por: Lee, Jung-Hwa, et al.
Publicado: (2006)

Balance and muscle power of children with Charcot-Marie-Tooth
por: Silva, Tais R., et al.
Publicado: (2014)

Preimplantation genetic diagnosis for Charcot-Marie-Tooth disease
por: Lee, Hyoung-Song, et al.
Publicado: (2013)

A SIMPLE explanation for Charcot-Marie-Tooth disease
por: Short, Ben
Publicado: (2012)

ACQUIRED PES CAVUS IN CHARCOT-MARIE-TOOTH DISEASE
por: Maranho, Daniel Augusto, et al.
Publicado: (2015)

Charcot Marie Tooth Disease. A Single Disorder?
por: Fontés, Michel
Publicado: (2018)

Impaired Mitochondrial Mobility in Charcot-Marie-Tooth Disease
por: Schiavon, Cara R., et al.
Publicado: (2021)

Emerging Therapies for Charcot-Marie-Tooth Inherited Neuropathies
por: Stavrou, Marina, et al.
Publicado: (2021)

Anaesthetic implications in patient with Charcot-Marie-Tooth disease
por: Kapoor, Hemlata, et al.
Publicado: (2021)

The Current State of Charcot–Marie–Tooth Disease Treatment
por: Okamoto, Yuji, et al.
Publicado: (2023)

A Rasch Analysis of the Charcot-Marie-Tooth Neuropathy Score (CMTNS) in a Cohort of Charcot-Marie-Tooth Type 1A Patients
por: Wang, Wenjia, et al.
Publicado: (2017)

Postural stabilization and balance assessment in Charcot–Marie–Tooth 1A subjects
por: Lencioni, T., et al.
Publicado: (2014)

Evolution of foot manifestations in children with Charcot-Marie-Tooth disease
por: Burns, Joshua, et al.
Publicado: (2008)

Defective α-tubulin acetylation in models of Charcot-Marie-Tooth
Publicado: (2011)

Correlates of calf cramp in children with Charcot-Marie-Tooth disease
por: Blyton, Fiona E, et al.
Publicado: (2012)

Hand weakness in Charcot-Marie-Tooth disease 1X
por: Arthur-Farraj, P.J., et al.
Publicado: (2012)

Challenges in modelling the Charcot-Marie-Tooth neuropathies for therapy development
por: Juneja, Manisha, et al.
Publicado: (2019)

Recent Advances in Drosophila Models of Charcot-Marie-Tooth Disease
por: Kitani-Morii, Fukiko, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mp3jkklraneovrp1jioer107s0